Novozymes, despite disappointing first quarter, promises sales growth in 2012

April 30, 2012 |

In Denmark, Novozymes has announced it expects to turn a first-quarter sales loss into a growth of 2% to 3% for the full year. Although recent sales have fallen up to 9% in local currencies, market share gains and the launch of a new enzyme has encouraged the CFO, Benny Loft. “We’ll catch up with the 9% sales decline in the fist quarter, and will end the year with sales growth at the same level as the expected U.S. market growth,” he said.

More on the story.

Category: Fuels

Thank you for visting the Digest.